Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Get Rating) from a strong-buy rating to a buy rating in a report issued on Monday. Several other research analysts also recently issued reports on UTHR. HC Wainwright upped their price objective on United Therapeutics from $248.00 to $255.00 and gave the stock a buy rating in […]
American Century Companies Inc. lifted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 904.3% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,496 shares of the biotechnology company’s stock after acquiring an additional 62,576 shares during the […]
Swiss National Bank lifted its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 7.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 106,500 shares of the biotechnology company’s stock after acquiring an additional 7,800 shares during the […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) has been assigned an average rating of “Buy” from the ten research firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) CEO Martine A. Rothblatt sold 3,000 shares of United Therapeutics stock in a transaction dated Tuesday, May 31st. The shares were sold at an average price of $230.85, for a total transaction of $692,550.00. Following the sale, the chief executive officer now owns 130 shares of the company’s […]